Scarica l'app Stockscreener
18.07
1.01%
0.18
Precedente Chiudi:
$17.89
Aprire:
$18.03
Volume 24 ore:
152.08K
Relative Volume:
0.88
Capitalizzazione di mercato:
$558.82M
Reddito:
$290.71M
Utile/perdita netta:
$-163.43M
Rapporto P/E:
-11.02
EPS:
-1.64
Flusso di cassa netto:
$11.70M
1 W Prestazione:
+4.57%
1M Prestazione:
-6.95%
6M Prestazione:
-15.52%
1 anno Prestazione:
-34.55%
Intervallo 1D:
$18.02
$18.63
Intervallo di 1 settimana:
$16.92
$18.89
Portata 52W:
$16.56
$30.68
Fulgent Genetics Inc Stock (FLGT) Company Profile
Nome
Fulgent Genetics Inc
Settore
Industria
Telefono
626-350-0537
Indirizzo
4399 SANTA ANITA AVE, EL MONTE
Confronta FLGT con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
FLGT
Fulgent Genetics Inc
|
18.07 | 558.82M | 290.71M | -163.43M | 11.70M | -1.64 |
|
TMO
Thermo Fisher Scientific Inc
|
521.66 | 199.82B | 42.37B | 6.14B | 7.78B | 15.26 |
|
DHR
Danaher Corp
|
238.83 | 173.66B | 23.74B | 3.89B | 4.98B | 7.93 |
|
A
Agilent Technologies Inc
|
138.14 | 38.64B | 6.51B | 1.29B | 1.37B | 3.82 |
|
IQV
Iqvia Holdings Inc
|
201.43 | 36.52B | 15.32B | 1.41B | 1.96B | 5.95 |
|
IDXX
Idexx Laboratories Inc
|
421.76 | 34.55B | 3.84B | 866.24M | 792.60M | 9.80 |
Fulgent Genetics Inc Stock (FLGT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2023-12-07 | Iniziato | UBS | Neutral |
| 2022-12-08 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2022-11-18 | Iniziato | Raymond James | Outperform |
| 2022-08-25 | Iniziato | Credit Suisse | Outperform |
| 2022-02-04 | Ripresa | Piper Sandler | Overweight |
| 2021-08-05 | Ripresa | Credit Suisse | Underperform |
| 2021-01-08 | Downgrade | Credit Suisse | Neutral → Underperform |
| 2020-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| 2020-08-20 | Iniziato | Oppenheimer | Outperform |
| 2020-05-29 | Iniziato | BTIG Research | Buy |
| 2019-11-05 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-03-01 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2017-11-07 | Downgrade | Raymond James | Outperform → Mkt Perform |
Mostra tutto
Fulgent Genetics Inc Borsa (FLGT) Ultime notizie
Fulgent Genetics CEO Ming Hsieh sells $40,663 in stock - Investing.com
StockNews.com Downgrades Fulgent Genetics (NASDAQ:FLGT) to Sell - Defense World
Principal Financial Group Inc. Sells 6,020 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
When (FLGT) Moves Investors should Listen - Stock Traders Daily
All You Need to Know About Fulgent Genetics (FLGT) Rating Upgrade to Strong Buy - MSN
10 Best Genomics Stocks To Buy Right Now - Insider Monkey
Fulgent Genetics, Inc. (FLGT): Among the Best Genomics Stocks to Buy Right Now - Yahoo Finance
Fulgent Genetics (NASDAQ:FLGT) Hits New 12-Month LowShould You Sell? - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Stock Rating Upgraded by StockNews.com - MarketBeat
Fulgent Genetics (NASDAQ:FLGT) Trading Up 4% – Here’s Why - Defense World
Fulgent Genetics (NASDAQ:FLGT) Trading 4% HigherWhat's Next? - MarketBeat
Fulgent Genetics stock hits 52-week low at $18.76 By Investing.com - Investing.com Australia
Fulgent Genetics stock hits 52-week low at $18.76 - Investing.com
Piper Sandler Issues Pessimistic Forecast for Fulgent Genetics (NASDAQ:FLGT) Stock Price - Defense World
Fulgent Genetics (NASDAQ:FLGT) Rating Lowered to “Sell” at StockNews.com - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Q3 2024 Earnings Call Transcript - Insider Monkey
(FLGT) Long Term Investment Analysis - Stock Traders Daily
Earnings call: Fulgent Genetics Q3 2024 results and growth strategies By Investing.com - Investing.com UK
Earnings call: Fulgent Genetics Q3 2024 results and growth strategies - Investing.com
Fulgent Genetics (NASDAQ:FLGT) Price Target Cut to $22.00 by Analysts at Piper Sandler - MarketBeat
Companies Like Fulgent Genetics (NASDAQ:FLGT) Are In A Position To Invest In Growth - Yahoo Finance
Fulgent Genetics Third Quarter 2024 Earnings: EPS Misses Expectations - Yahoo Finance
State of Alaska Department of Revenue Has $247,000 Stake in Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics (NASDAQ:FLGT) Trading Down 10.8%Time to Sell? - MarketBeat
Fulgent Genetics Reports Strong Q3 2024 Results - Yahoo Finance
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: St - GuruFocus.com
Fulgent Genetics Inc (FLGT) Q3 2024 Earnings Call Highlights: Strategic Growth Amid Revenue Decline - Yahoo Finance UK
Fulgent Genetics Inc (FLGT) Quarterly 10-Q Report - Quartzy
Fulgent Reports Third Quarter 2024 Financial Results - BioSpace
Fulgent Genetics earnings beat by $0.46, revenue fell short of estimates - Investing.com Canada
Fulgent Genetics (NASDAQ:FLGT) Updates FY24 Earnings Guidance - MarketBeat
Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Canada Finance
Fulgent Genetics Inc Reports Q3 2024 Earnings: Non-GAAP EPS of $0.31, Revenue at $71.7 Million - GuruFocus.com
Fulgent Genetics (NASDAQ:FLGT) Issues FY 2024 Earnings Guidance - MarketBeat
Fulgent to Participate in Upcoming Conferences - Business Wire
Creative Planning Buys 8,075 Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) - Defense World
Fulgent Genetics, Inc. (NASDAQ:FLGT) Short Interest Up 5.6% in October - Defense World
Fulgent Genetics secures $99M VA contract for genetic testing By Investing.com - Investing.com Australia
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains? - Yahoo Finance
Positive week for Fulgent Genetics, Inc. (NASDAQ:FLGT) institutional investors who lost 20% over the past year - Simply Wall St
Fulgent Genetics (FLGT) Scheduled to Post Quarterly Earnings on Friday - Defense World
Fulgent Genetics (FLGT) to Release Earnings on Friday - MarketBeat
Fulgent Genetics secures $99M VA contract for genetic testing - Investing.com India
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1 - BioSpace
Fulgent Genetics (NASDAQ:FLGT) Reaches New 52-Week LowWhat's Next? - MarketBeat
Fulgent Genetics stock hits 52-week low at $18.9 amid market shifts - Investing.com
(FLGT) On The My Stocks Page - Stock Traders Daily
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024 - BioSpace
Fulgent Genetics Inc Azioni (FLGT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.43%
0.41%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):